Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?
Future Oncol
; 17(36): 5163-5175, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636250
3.
Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database.
J Clin Gastroenterol
; 53(9): 693-698, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30148766
4.
Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib.
Oncologist
; 22(2): 208-212, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167571
5.
Patient-Focused Drug Development: A New Direction for Collaboration.
Med Care
; 53(1): 9-17, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25494232
6.
Characterizing genetic variants for clinical action.
Am J Med Genet C Semin Med Genet
; 166C(1): 93-104, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634402
7.
Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study.
Cancer Treat Res Commun
; 31: 100555, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421820
8.
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.
J Med Econ
; 25(1): 108-118, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927520
9.
Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
PLoS One
; 17(1): e0261336, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073335
10.
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.
Clin Lymphoma Myeloma Leuk
; 22(9): 670-679, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614009
11.
Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs.
Clinicoecon Outcomes Res
; 13: 801-807, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531668
12.
Attitudes and Perceptions Toward COVID-19 Digital Surveillance: Survey of Young Adults in the United States.
JMIR Form Res
; 5(1): e23000, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347420
13.
Abaloparatide Real-World Patient Experience Study.
JBMR Plus
; 5(3): e10457, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778325
14.
Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.
Patient Prefer Adherence
; 15: 453-465, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658769
15.
Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.
Adv Ther
; 37(8): 3606-3618, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642965
16.
Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.
Emerg Infect Dis
; 14(8): 1280-3, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18680656
17.
Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Pharmacotherapy
; 28(8): 992-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18657016
18.
Practice Patterns and Treatment Challenges in Acute Postoperative Pain Management: A Survey of Practicing Physicians.
Pain Ther
; 7(2): 205-216, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367388
19.
The effect of incentive-based formularies on prescription-drug utilization and spending.
N Engl J Med
; 349(23): 2224-32, 2003 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-14657430
20.
The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees.
Health Serv Res
; 42(5): 1926-42, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17850526